Immunology and Microbiology
Anaphylaxis
80%
Pig
69%
Xenotransplantation
69%
Glycocalyx
64%
Xenograft
50%
Leukocyte Activation
40%
Liquid
37%
Inflammation Response
32%
Platelet
32%
Blood Pressure
32%
Low Drug Dose
32%
Mast Cell
26%
Neutrophil
26%
Tumor Necrosis Factor Alpha
25%
Syndecan 1
24%
Caspase
20%
Innate Immune System
20%
Drug Megadose
19%
Immunology
19%
Lipocalin
18%
Myoblast
16%
Inflammatory Cell
16%
Splenic B Cell
16%
Resistin
16%
Preclinical Study
16%
Cell Death
16%
Enzyme Activity
16%
Fibrin Deposition
16%
Granzyme B
16%
HLA Antibody
16%
Antibody Mediated Rejection
16%
Thrombocyte Aggregation
16%
Kidney Transplantation
16%
Antibody Response
16%
Thrombocyte Activation
16%
Cytomegalovirus Infection
16%
Peripheral Blood Mononuclear Cell
16%
Antibodies
16%
Cell Activation
12%
Murine Cytomegalovirus
12%
CD8
11%
Leukocyte
11%
Gene Expression
11%
Fibrin Formation
10%
Neutrophil Granulocyte
10%
Interleukin 6
9%
Immune Response
9%
Upregulation
9%
Multiple Drug Dose
9%
Natural Killer Cell
9%
Medicine and Dentistry
Biological Marker
100%
Sepsis
59%
Glycocalyx
58%
Platelet
48%
Emergency Department
43%
Serositis
38%
Restylane
36%
Blood Pressure
34%
Pulse Wave Velocity
26%
Syndecan 1
24%
Flow Cytometry
22%
Shock (Circulatory)
21%
Infection
19%
Tumor Necrosis Factor
19%
Cardiovascular Risk
17%
Low Drug Dose
16%
Interferon Type I
16%
Myoblast
16%
Real-Time Polymerase Chain Reaction
16%
Neutrophil Gelatinase Associated Lipocalin
16%
Resistin
16%
Respiratory Failure
16%
Transient Ischemic Attack
16%
Enzyme Activity
16%
DNA Hybridization
16%
Splenic B Cell
16%
Brain Infarction
16%
Risk Evaluation
16%
Sensitivity and Specificity
16%
Cell Death
16%
Hypoxemia
16%
Anaphylaxis
16%
Tryptase
16%
Granzyme B
16%
Caspase 3
16%
Resuscitation
16%
Infusion Fluid
16%
Programmed Cell Death
12%
Infarction
12%
Heme Oxygenase 1
12%
CD8 Antigen
11%
Bleeding
11%
Clinical Trial
10%
Leukocyte Activation
9%
Interleukin 6
9%
Leukocyte
8%
In Vitro
8%
Apoplexy
8%
Neutrophil
8%
Protoporphyrin Cobalt
8%
Biochemistry, Genetics and Molecular Biology
Pig
55%
Liquid
52%
Glycocalyx
40%
Animal Models
35%
Blood Pressure
32%
Platelet
32%
Crystalloid
32%
Restylane
28%
Hydroxyethyl Starch
21%
Real-Time Polymerase Chain Reaction
20%
Natural Killer Cell
20%
Clinical Trial
16%
DNA Hybridization
16%
Macrophage
16%
Long Term Survival
16%
Immunological Tolerance
16%
Solution and Solubility
16%
Genetics
16%
Primate Model
16%
Transgenic Animal
16%
Low Drug Dose
16%
B Cell
16%
Neutrophil Granulocyte
16%
Granzyme B
16%
Humoral Immunity
16%
Peripheral Blood Mononuclear Cell
16%
Preclinical Study
16%
Coagulopathy
16%
Interferon Type I
16%
Immunity
16%
Tumor Necrosis Factor
11%
CD8
11%
Greyhound
10%
Synapsin I
10%
Y Chromosome
10%
Interleukin 6
9%
Multiple Drug Dose
9%
Tumor Necrosis Factor Alpha
9%
Pulse Wave
8%
Monoclonal Antibody
8%
Clusterin
8%
Cystatin C
8%
Gamma-Glutamyl Transpeptidase
8%
Gelatinase B
8%
MMP9
8%
Cell Activation
6%
Leukocyte
6%
Syndecan
6%
Gelatinase
6%
Lipocalin
6%